Oxidative capacity interacts with oxygen delivery to determine maximal O2 uptake in rat skeletal muscles in situ

被引:30
作者
Hepple, RT
Hagen, JL
Krause, DJ
机构
[1] Univ Calgary, Fac Kinesiol, Calgary, AB T2N 1N4, Canada
[2] Univ Calgary, Fac Med, Calgary, AB T2N 1N4, Canada
来源
JOURNAL OF PHYSIOLOGY-LONDON | 2002年 / 541卷 / 03期
关键词
D O I
10.1113/jphysiol.2001.013649
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Based on proportional changes in (V)over dot(O2,max) with alterations in O-2 delivery, it is widely held that O-2 availability limits (V)over dot(O2,max). In contrast, reductions in (V)over dot(O2,max) are also seen when mitochondrial oxidative capacity is reduced. Taken collectively, these prior results are consistent with the notion that there is not a single-step limitation to We used a pump-perfused rat hindlimb model to test the hypothesis that combining moderate reductions in O-2 delivery and mitochondrial oxidative capacity would yield a greater reduction in (V)over dot(O2,max) than seen when performing each intervention independently, demonstrating an interaction between O-2 supply and mitochondrial oxidative capacity in determining (V)over dot(O2,max). Four groups of animals were studied: two in high 0, delivery conditions (hindlimb O-2 delivery: 88 I mumol O-2 min(-1); mean S.E.M.) and two in moderately reduced 0, delivery conditions (66 +/- 2 mumol O-2 min(-1)). One group at each level of O-2 delivery was treated with 0.1 muM myxothiazol to reduce mitochondrial oxidative capacity via competitive inhibition of NADH cytochrome c reductase (V)over dot(O2,max) in control animals (no myxothiazol) was 29 % lower in the moderately reduced O-2 delivery group (592 +/- 24 mmol O-2 min(-1) (100 g)(-1)); P < 0.05) than in the high O-2 delivery group (833 +/- 63 mumol O-2 min(-1) (100 g) (-1)). Similarly, (V)over dot(O2,max) was reduced by 29 % (594 +/- 22 mumol O-2 min(-1) (100 g)(-1)); P < 0.05) in myxothiazol-treated animals in high O-2 delivery conditions compared to control animals in high O-2 delivery conditions. When myxothiazol treatment was combined with moderately reduced O-2 delivery, (V)over dot(O2,max) was reduced by an additional 18 % (484 +/- 21 mumol O-2 min(-1) (100 g)(-1)); P < 0.05) compared to either intervention performed independently. These results show that O-2 supply and mitochondrial oxidative capacity interact to determine (V)over dot(O2,max).
引用
收藏
页码:1003 / 1012
页数:10
相关论文
共 38 条
[1]   MAXIMAL PERFUSION OF SKELETAL-MUSCLE IN MAN [J].
ANDERSEN, P ;
SALTIN, B .
JOURNAL OF PHYSIOLOGY-LONDON, 1985, 366 (SEP) :233-249
[2]   THE EFFECTS ON THE RESPIRATION AND PERFORMANCE DURING EXERCISE OF ADDING OXYGEN TO THE INSPIRED AIR [J].
BANNISTER, RG ;
CUNNINGHAM, DJC .
JOURNAL OF PHYSIOLOGY-LONDON, 1954, 125 (01) :118-137
[3]   Limiting factors for maximum oxygen uptake and determinants of endurance performance [J].
Bassett, DR ;
Howley, ET .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2000, 32 (01) :70-84
[4]  
Conley KE, 2001, J EXP BIOL, V204, P3189
[5]   DEFINING HYPOXIA - A SYSTEMS VIEW OF VO2, GLYCOLYSIS, ENERGETICS, AND INTRACELLULAR PO-2 [J].
CONNETT, RJ ;
HONIG, CR ;
GAYESKI, TEJ ;
BROOKS, GA .
JOURNAL OF APPLIED PHYSIOLOGY, 1990, 68 (03) :833-842
[6]   OPERATION EVEREST-II - MAXIMAL OXYGEN-UPTAKE AT EXTREME ALTITUDE [J].
CYMERMAN, A ;
REEVES, JT ;
SUTTON, JR ;
ROCK, PB ;
GROVES, BM ;
MALCONIAN, MK ;
YOUNG, PM ;
WAGNER, PD ;
HOUSTON, CS .
JOURNAL OF APPLIED PHYSIOLOGY, 1989, 66 (05) :2446-2453
[7]   BIOCHEMICAL ADAPTATION OF MITOCHONDRIA, MUSCLE, AND WHOLE-ANIMAL RESPIRATION TO ENDURANCE TRAINING [J].
DAVIES, KJA ;
PACKER, L ;
BROOKS, GA .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1981, 209 (02) :539-554
[8]   EFFECTS OF REDUCED O-2 DELIVERY WITH ANEMIA, HYPOXIA, OR ISCHEMIA ON PEAK VO2 AND FORCE IN SKELETAL-MUSCLE [J].
DODD, SL ;
POWERS, SK ;
BROOKS, E ;
CRAWFORD, MP .
JOURNAL OF APPLIED PHYSIOLOGY, 1993, 74 (01) :186-191
[9]   MINIMUM INTRACELLULAR PO2 FOR MAXIMUM CYTOCHROME TURNOVER IN RED MUSCLE INSITU [J].
GAYESKI, TEJ ;
CONNETT, RJ ;
HONIG, CR .
AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 252 (05) :H906-H915
[10]   MYXOTHIAZOL, AN ANTIBIOTIC FROM MYXOCOCCUS-FULVUS (MYXOBACTERALES) .1. CULTIVATION, ISOLATION, PHYSICOCHEMICAL AND BIOLOGICAL PROPERTIES [J].
GERTH, K ;
IRSCHIK, H ;
REICHENBACH, H ;
TROWITZSCH, W .
JOURNAL OF ANTIBIOTICS, 1980, 33 (12) :1474-1479